Showing results (961-970 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|July 1, 2015
Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestryAna Alfirevic, Jill Durocher, Anisa Elati, et al.Pharmacogenomics|July 1, 2015
Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomersDolores Ochoa, Rocío Prieto-Pérez, Manuel Román, et al.Pharmacogenomics|July 28, 2016
Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicineJi-Ye Yin, Xi Li, Hong-Hao Zhou, et al.Pharmacogenomics|July 28, 2016
CYP2D6 ultra-rapid metabolizer phenotype not associated with attempted suicide in a large sample of psychiatric inpatientsDustin B Stephens, Jose de LeonPharmacogenomics|April 28, 2020
CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorderMikhail Sergeevich Zastrozhin, Valentin Yurievich Skryabin, Alexander Sergeevich Sorokin, et al.Pharmacogenomics|April 16, 2020
An assessment of patient perspectives on pharmacogenomics educational materialsGladys B Asiedu, Lila J Finney Rutten, Amenah Agunwamba, et al.Pharmacogenomics|May 23, 2001
The significance of genetic polymorphisms in modulating the response to lipid-lowering drugsM M Hoffmann, B R Winkelmann, H Wieland, et al.Pharmacogenomics|March 22, 2001
The relative power of SNPs and haplotype as genetic markers for association testsJ S BaderPageof 276